Annual CFO
-$9.38 M
-$2.12 M-29.14%
December 31, 2023
Summary
- As of February 7, 2025, SCNI annual cash flow from operations is -$9.38 million, with the most recent change of -$2.12 million (-29.14%) on December 31, 2023.
- During the last 3 years, SCNI annual CFO has risen by +$13.18 million (+58.41%).
- SCNI annual CFO is now -676.98% below its all-time high of -$1.21 million, reached on December 1, 2013.
Performance
SCNI Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$2.04 M
-$280.00 K-15.93%
September 1, 2024
Summary
- As of February 7, 2025, SCNI quarterly cash flow from operations is -$2.04 million, with the most recent change of -$280.00 thousand (-15.93%) on September 1, 2024.
- Over the past year, SCNI quarterly CFO has dropped by -$575.00 thousand (-39.30%).
- SCNI quarterly CFO is now -661.87% below its all-time high of -$267.50 thousand, reached on September 1, 2016.
Performance
SCNI Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$6.48 M
+$184.00 K+2.76%
September 1, 2024
Summary
- As of February 7, 2025, SCNI TTM cash flow from operations is -$6.48 million, with the most recent change of +$184.00 thousand (+2.76%) on September 1, 2024.
- Over the past year, SCNI TTM CFO has increased by +$1.30 million (+16.72%).
- SCNI TTM CFO is now -1240.22% below its all-time high of -$483.80 thousand, reached on March 1, 2014.
Performance
SCNI TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SCNI Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -29.1% | -39.3% | +16.7% |
3 y3 years | +58.4% | -243.7% | +10.8% |
5 y5 years | +38.2% | -243.7% | +10.8% |
SCNI Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -29.1% | at low | -243.7% | +44.4% | -486.8% | +30.9% |
5 y | 5-year | -29.1% | +58.4% | -243.7% | +44.4% | -486.8% | +30.9% |
alltime | all time | -677.0% | +58.4% | -661.9% | +80.5% | -1240.2% | +60.1% |
Scinai Immunotherapeutics Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$2.04 M(+15.9%) | -$6.48 M(-2.8%) |
Jun 2024 | - | -$1.76 M(+20.2%) | -$6.67 M(-14.4%) |
Mar 2024 | - | -$1.46 M(+19.4%) | -$7.79 M(-17.0%) |
Dec 2023 | -$9.38 M(+29.1%) | -$1.23 M(-44.9%) | -$9.38 M(+7.2%) |
Sep 2023 | - | -$2.22 M(-22.7%) | -$8.75 M(+3.8%) |
Jun 2023 | - | -$2.88 M(-6.0%) | -$8.43 M(-8.6%) |
Mar 2023 | - | -$3.06 M(+415.9%) | -$9.22 M(+26.9%) |
Dec 2022 | -$7.26 M(-2.2%) | -$593.00 K(-68.8%) | -$7.26 M(+8.9%) |
Sep 2022 | - | -$1.90 M(-48.1%) | -$6.67 M(+39.9%) |
Jun 2022 | - | -$3.67 M(+231.7%) | -$4.77 M(+331.7%) |
Mar 2022 | - | -$1.10 M(-82.1%) | -$1.10 M(-90.8%) |
Dec 2021 | -$7.43 M(-67.1%) | - | - |
Dec 2020 | -$22.56 M(+1.4%) | - | - |
Dec 2019 | -$22.25 M(+46.5%) | - | - |
Jun 2019 | - | -$6.17 M(+69.2%) | -$11.98 M(-26.3%) |
Mar 2019 | - | -$3.65 M(+230.7%) | -$16.25 M(+7.0%) |
Dec 2018 | -$15.19 M | -$1.10 M(+3.7%) | -$15.19 M(+5.8%) |
Sep 2018 | - | -$1.06 M(-89.8%) | -$14.35 M(-0.0%) |
Jun 2018 | - | -$10.44 M(+305.0%) | -$14.36 M(+198.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2018 | - | -$2.58 M(+858.4%) | -$4.82 M(+66.5%) |
Dec 2017 | -$2.89 M(+15.2%) | -$269.00 K(-74.8%) | -$2.89 M(-9.2%) |
Sep 2017 | - | -$1.07 M(+18.8%) | -$3.19 M(+33.6%) |
Jun 2017 | - | -$899.70 K(+37.5%) | -$2.38 M(+3.1%) |
Mar 2017 | - | -$654.40 K(+16.3%) | -$2.31 M(-7.9%) |
Dec 2016 | -$2.51 M(-4.6%) | -$562.50 K(+110.3%) | -$2.51 M(-7.8%) |
Sep 2016 | - | -$267.50 K(-67.7%) | -$2.72 M(-11.2%) |
Jun 2016 | - | -$827.80 K(-2.8%) | -$3.06 M(+2.6%) |
Mar 2016 | - | -$851.70 K(+10.0%) | -$2.99 M(+13.6%) |
Dec 2015 | -$2.63 M(+35.3%) | -$774.00 K(+26.8%) | -$2.63 M(+12.4%) |
Sep 2015 | - | -$610.50 K(-18.8%) | -$2.34 M(+7.0%) |
Jun 2015 | - | -$751.50 K(+52.1%) | -$2.19 M(+11.8%) |
Mar 2015 | - | -$494.10 K(+2.2%) | -$1.95 M(+0.5%) |
Dec 2014 | -$1.94 M(+61.0%) | -$483.70 K(+5.9%) | -$1.94 M(+33.1%) |
Sep 2014 | - | -$456.70 K(-12.2%) | -$1.46 M(+45.5%) |
Jun 2014 | - | -$520.40 K(+7.6%) | -$1.00 M(+107.6%) |
Mar 2014 | - | -$483.80 K | -$483.80 K |
Dec 2013 | -$1.21 M(-35.6%) | - | - |
Dec 2012 | -$1.88 M(-26.2%) | - | - |
Dec 2011 | -$2.54 M | - | - |
FAQ
- What is Scinai Immunotherapeutics annual cash flow from operations?
- What is the all time high annual CFO for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics annual CFO year-on-year change?
- What is Scinai Immunotherapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics quarterly CFO year-on-year change?
- What is Scinai Immunotherapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics TTM CFO year-on-year change?
What is Scinai Immunotherapeutics annual cash flow from operations?
The current annual CFO of SCNI is -$9.38 M
What is the all time high annual CFO for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high annual cash flow from operations is -$1.21 M
What is Scinai Immunotherapeutics annual CFO year-on-year change?
Over the past year, SCNI annual cash flow from operations has changed by -$2.12 M (-29.14%)
What is Scinai Immunotherapeutics quarterly cash flow from operations?
The current quarterly CFO of SCNI is -$2.04 M
What is the all time high quarterly CFO for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high quarterly cash flow from operations is -$267.50 K
What is Scinai Immunotherapeutics quarterly CFO year-on-year change?
Over the past year, SCNI quarterly cash flow from operations has changed by -$575.00 K (-39.30%)
What is Scinai Immunotherapeutics TTM cash flow from operations?
The current TTM CFO of SCNI is -$6.48 M
What is the all time high TTM CFO for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high TTM cash flow from operations is -$483.80 K
What is Scinai Immunotherapeutics TTM CFO year-on-year change?
Over the past year, SCNI TTM cash flow from operations has changed by +$1.30 M (+16.72%)